Quest Diagnostics Incorporated (DGX) |
| 191.42 -2.74 (-1.41%) 04-15 16:00 |
| Open: | 193.17 |
| High: | 194.28 |
| Low: | 191.04 |
| Volume: | 664,535 |
| Market Cap: | 21,187(M) |
| PE Ratio: | 21.9 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Diagnostics & Research |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 205.00 |
| Resistance 1: | 199.17 |
| Pivot price: | 196.13 |
| Support 1: | 189.73 |
| Support 2: | 157.86 |
| 52w High: | 213.5 |
| 52w Low: | 160.02 |
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
| EPS | 8.760 |
| Book Value | 65.180 |
| PEG Ratio | 0.00 |
| Gross Profit | 33.494 |
| Profit Margin (%) | 8.99 |
| Operating Margin (%) | 13.97 |
| Return on Assets (ttm) | 6.2 |
| Return on Equity (ttm) | 14.8 |
Wed, 15 Apr 2026
Quest Diagnostics (DGX) down 4.2% since last earnings report: Can it rebound? - MSN
Wed, 15 Apr 2026
Here's How Quest Diagnostics Is Placed Ahead of Q1 Earnings - TradingView — Track All Markets
Tue, 14 Apr 2026
Q4 Earnings Roundup: Quest (NYSE:DGX) And The Rest Of The Testing & Diagnostics Services Segment - Yahoo Finance
Tue, 14 Apr 2026
Quest Diagnostics (DGX) Reports Next Week: Wall Street Expects Earnings Growth - Yahoo Finance
Fri, 10 Apr 2026
Quest Diagnostics Inc (DGX) Stock Down 3.2% but Still Overvalued -- GF Score: 81/100 - GuruFocus
Fri, 10 Apr 2026
Quest Diagnostics Inc. stock underperforms Friday when compared to competitors - MarketWatch
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |